News
-
23.06.2009
Salvacyl®, developed by Debiopharm, is launched in two European countries - a new therapeutic avenue for the treatment of sexual deviations - -
18.06.2009
Debiopharm Group and Moffitt Cancer Center sign development and commercialisation agreement for small molecule Debio 0928 in early preclinical development for treatment of solid tumours - A novel drug with potential to block cancer cell proliferation
Home
| Careers |
Our PeopleApproximately 300 people of more than 18 nationalities are employed at Debiopharm Group worldwide - including Switzerland, France, China and North America. Our people have a high level of science education with 42 % scientists (MDs, PhDs, pharmacists). In addition to our internal expertise, we also work with an extensive international network of experts, enabling us to tap into top-level scientific, development and business capabilities. Positions with DebiopharmWe are an international group of companies and we strive to recruit highly competent, flexible and hard-working people for each position. We currently have the following openings:Lausanne 09-Jun-2009 23-Apr-2009 07-Apr-2009 13-Feb-2009 Click here for a spontaneous job application. Martigny 10-Feb-2009 05-Feb-2008 Click here for a spontaneous job application. Montreal Click here for a spontaneous job application. Paris Click here for a spontaneous job application. |